Holland Capital Invests in Blyott
Amsterdam / Oostkamp, 13 September 2024 – Holland Capital has invested in Blyott, a company that provides real-time solutions for tracking medical equipment in healthcare organisations.
Innovative Real-Time Tags
The increasing workload in healthcare demands innovative solutions to alleviate the pressure on healthcare staff. Blyott offers this solution by developing tags that display the real-time location of medical devices within healthcare organisations. In addition to location tracking, the tags utilize AI to provide insights into other aspects, such as equipment usage. This not only reduces the time healthcare staff spends searching for equipment but also contributes to improved asset management.
Operational Efficiency and Cost Savings
The tags use Bluetooth Low Energy technology, which can be easily implemented through existing Wi-Fi networks. With this technology, Blyott aims to enhance operational efficiency and reduce costs by offering better insights into the location, use, and consumption of medical equipment. This allows healthcare staff to focus on their core tasks, leading to an improvement in care quality. Additionally, unnecessary equipment purchases are avoided, contributing to significant cost savings. The tags are also used for efficient inventory management, which is crucial for suppliers of medical equipment.
The Partnership
Through this partnership, Blyott has found a partner to help realize and accelerate its growth ambitions.
Gery Pollet, Founder & CEO of Blyott: “I look forward to working with Holland Capital, given their experience and focus on healthcare investments. Holland Capital is the right partner to accelerate our international growth.”
Sterre Witteveen, Investment Manager at Holland Capital: “At Holland Capital, we are constantly searching for cost-efficient innovations that have an impact in healthcare. With Blyott’s platform, not only does it free up valuable time for healthcare staff, but it also helps avoid unnecessary medical equipment purchases. We look forward to rolling out Blyott globally with the experienced management team.”
About Blyott
Founded in 2019, Blyott emerged from the recognition that hospitals were purchasing up to 20% more equipment than necessary due to frequent loss or misplacement. With the Blyott Insights Module, based on AI, healthcare organisations and suppliers can gain practical insights into equipment usage, inventory management, and make data-driven adjustments where needed. www.blyot.com
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Benelux and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
Highcare supports management buy-out Zorgzuster
Roosendaal/Maastricht, 27 November 2018 – Highcare and Ralph Smeets acquire all shares of Zorgzuster Nederland from Start People (part of USG People The Netherlands). Ralph Smeets has founded Zorgzuster in 2010. Highcare is the employment and deployment agency in the...
Holland Venture invests in WSO2 integrator Yenlo
Amsterdam, 19 November 2018 – Private Equity firm Holland Venture invests in Yenlo, the leading integration specialist on WSO2 open source middleware technology. The management and shareholders have set a target for the coming years to strengthen the growth of the...
Holland Venture sells its shares in QSight IT to KPN
Amsterdam, October 3, 2017 - On the 2nd of October, Holland Venture and the other (management) the signed the acquisition contracts to sell their shares in QSight IT to Dutch telecom and ICT provider KPN. QSight IT is a leading Dutch player in the field of...
Holland Venture invests in LivAssured to support further development of the NightWatch
A groundbreaking detection system for nocturnal epileptic attacks Amsterdam, 20 September 2018 - Investment company Holland Venture invests with Oost NL and Health Innovations Fund in LivAssured, which developed the revolutionary NightWatch in collaboration...
Holland Venture closed a new fund to support innovation in healthcare
Amsterdam, 20 September 2018 – Holland Venture closed a new healthcare innovation fund which will invest in approx. 10 Dutch healthcare start-ups, active in the field of medical devices, diagnostics and digital health. The aim of the fund is to support entrepreneurs...
Quantib presents revolutionary software for dementia and MS diagnosis support and tracking
Rotterdam, The Netherlands – August 1st 2018. Quantib, market leader in artificial intelligence tools for radiology, released a major upgrade of their dementia and MS diagnosis support software Quantib™ ND. A substantial list of new features supporting the diagnosis...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl